Serena Cardillo, MD Associate Professor of Clinical Medicine Associate Program Director, Internal Medicine Residency Division of Endocrinology, Diabetes, and Metabolism Perelman School of Medicine University of Pennsylvania Philadelphia, PA
John J. Russell, MD Director, Family Medicine Residency Program Abington Memorial Hospital Clinical Professor of Family and Community Medicine Thomas Jefferson University Sidney Kimmel College of Medicine Philadelphia, PA
The management of type 2 diabetes (T2D) remains a clinical challenge as patients continue to struggle with achieving therapeutic goals. While there are many treatment options for T2D, there is relatively limited guidance on selection of second- and third-line treatments. This activity will review the most recent T2D treatment guidelines (including strategies for patient communication), and address incretin therapies and their role as monotherapy and in combination with other agents in the management of T2D.
. Target Audience
This educational activity is designed for primary care physicians, nurse practitioners, PAs, nurses, and others who care for patients with T2D.
Upon completion of this educational activity, the participant should be able to:
Review current treatment guidelines for managing T2D.
Outline the mechanisms of action of major classes of diabetes medications.
Discuss the therapeutic role of incretin-based therapies, alone or in combination with conventional treatments, in the management of T2D.
Incorporate recently approved fixed-ratio combination injectables into treatment plans for patients with T2D.
Outline recommended strategies and goals for clinician/patient communication about the management of T2D.
It is our policy to ensure balance, independence, objectivity, and scientific rigor in all of our educational programs. Faculty and course directors have disclosed relevant financial relationships with commercial companies, and Penn State has a process in place to resolve any conflict of interest.
Dr. Cardillo has nothing to disclose.
Dr. Russell has disclosed the following:
Consultant/advisor and speakers bureau: Sanofi Pasteur
Penn State staff involved in the development and review of this activity have nothing to disclose.
MCM Education staff involved in the development and review of this activity have nothing to disclose.
Faculty members are required to inform the audience when they are discussing off-label or unapproved uses of devices or drugs. Devices or drugs that are still undergoing clinical trials are identified as such and should not be portrayed as standard, accepted therapy. Please consult full prescribing information before using any product mentioned in this activity. If using products in an investigational, off-label manner, it is the responsibility of the prescribing physician to monitor the medical literature to determine recommended dosages and uses of the drugs. Neither the publisher nor the providers promote the use of any agent outside of approved labeling. Credit Statements
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Penn State College of Medicine and MCM Education. Penn State College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
CREDIT DESIGNATION STATEMENT
Penn State College of Medicine designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
For questions regarding CME credit, contact Penn State Continuing Education at 717-531-6483 or ContinuingEd@hmc.psu.edu. Please reference activity code G6235-18-T. Commercial Support Statements
This activity is supported by an educational grant from Sanofi US.
The opinions expressed in this educational activity are those of the faculty and do not necessarily reflect the opinions or recommendations of their affiliated institutions, the publisher, Penn State College of Medicine, or Sanofi US. Any medications, diagnostic procedures, or treatments discussed by the program presenters should not be used by clinicians or other health care professionals without first evaluating their patients’ conditions, considering possible contraindications or risks, reviewing any applicable manufacturer’s product information, and comparing any therapeutic approach with the recommendations of other authorities.